Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mariam Saad, Ella Castellano & Ahmad A. Tarhini. (2023) Clinical updates in neoadjuvant immunotherapy for melanoma before surgery. Expert Review of Clinical Immunology 0:0, pages 1-17.
Read now
Read now
Articles from other publishers (28)
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou & Athanasios Armakolas. (2023) Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers. International Journal of Molecular Sciences 24:20, pages 15332.
Crossref
Crossref
Kaewta Rattanapisit, Christine Joy I. Bulaon, Richard Strasser, Hongyan Sun & Waranyoo Phoolcharoen. (2023) In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody. Scientific Reports 13:1.
Crossref
Crossref
Wei Tang, Jun Chen, Tianlong Ji & Xiufeng Cong. (2023) TIGIT, a novel immune checkpoint therapy for melanoma. Cell Death & Disease 14:7.
Crossref
Crossref
Vinod K. Nelson, Mohana Vamsi Nuli, Juturu Mastanaiah, Mohamed Saleem T. S.Geetha Birudala, Yahya F. Jamous, Omar Alshargi, Kranthi Kumar Kotha, Hari Hara Sudhan, Ravishankar Ram Mani, Alagusundaram Muthumanickam, Divya Niranjan, Nem Kumar Jain, Ankur Agrawal, Arvind Singh Jadon, Vinyas Mayasa, Niraj Kumar Jha, Adriana Kolesarova, Petr Slama & Shubhadeep Roychoudhury. (2023) Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids. Frontiers in Endocrinology 14.
Crossref
Crossref
Ika Nurlaila. 2023. Immune Checkpoint Inhibitors - New Insights and Recent Progress. Immune Checkpoint Inhibitors - New Insights and Recent Progress.
Wangqi Du, Peipei Jiang, Qingfeng Li, He Wen, Maolin Zheng, Jing Zhang, Yanru Guo, Jia Yang, Weixu Feng, Sisi Ye, Saidu Kamara, Pengfei Jiang, Jun Chen, Wenshu Li, Shanli Zhu & Lifang Zhang. (2023) Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants. Microbiology Spectrum 11:1.
Crossref
Crossref
Seon-Mi Lee, Sanghoon Lee, Hyun-Woong Cho, Kyung-Jin Min, Jin-Hwa Hong, Jae-Yun Song, Jae-Kwan Lee & Nak-Woo Lee. (2023) Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?. International Journal of Molecular Sciences 24:2, pages 974.
Crossref
Crossref
Azmi Yerlikaya & Sezgin Zeren. (2023) Molecular Pathways, Targeted Therapies, and Proteomic
Investigations of Colorectal Cancer. Current Molecular Medicine 23:1, pages 2-12.
Crossref
Crossref
Armita Mahdavi Gorabi, Mehrnaz Sadat Ravari, Mohammad-Javad Sanaei, Soodabeh Davaran, Prashant Kesharwani & Amirhossein Sahebkar. (2022) Immune checkpoint blockade in melanoma: Advantages, shortcomings and emerging roles of the nanoparticles. International Immunopharmacology 113, pages 109300.
Crossref
Crossref
Zhengjie Meng, Xue Fang, Bowen Fu, Cheng Qian, Zheng Yang, Yunhao Bai, Xinyue Tao, Haixiao Huang, Chenyu Ma, Wenjun Miao, Hao Ren, Aiyun Wang & Xueming Li. (2022) Tumor immunotherapy boosted by R837 nanocrystals through combining chemotherapy and mild hyperthermia. Journal of Controlled Release 350, pages 841-856.
Crossref
Crossref
Manasi P. Jogalekar, Ramya Lakshmi Rajendran, Fatima Khan, Crismita Dmello, Prakash Gangadaran & Byeong-Cheol Ahn. (2022) CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments. Frontiers in Immunology 13.
Crossref
Crossref
Stinne R. Greisen, Maithri Aspari & Bent Deleuran. (2022) Co-Inhibitory Molecules – Their Role in Health and Autoimmunity; Highlighted by Immune Related Adverse Events. Frontiers in Immunology 13.
Crossref
Crossref
Md. Mominur Rahman, Tapan Behl, Md. Rezaul Islam, Md. Noor Alam, Md. Mohaimenul Islam, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya & Simona Gabriela Bungau. (2022) Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer. Molecules 27:12, pages 3798.
Crossref
Crossref
Yang Yu, Huiwen Tang, Debora Franceschi, Prabhakar Mujagond, Aneesha Acharya, Yupei Deng, Bernd Lethaus, Vuk Savkovic, Rüdiger Zimmerer, Dirk Ziebolz, Simin Li & Gerhard Schmalz. (2022) Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival. Frontiers in Medicine 8.
Crossref
Crossref
Mohammed H. Ahmed, Isaias Hernández-Verdin, Franck Bielle, Maïté Verreault, Julie Lerond, Agusti Alentorn, Marc Sanson & Ahmed Idbaih. (2022) Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, pages 1-9.
Crossref
Crossref
Aatman S. Doshi & Kirtika H. Asrani. 2022. Cancer Immunology and Immunotherapy. Cancer Immunology and Immunotherapy
19
61
.
Farzaneh Darbeheshti. 2022. The Immunogenetics of Dermatologic Diseases. The Immunogenetics of Dermatologic Diseases
383
396
.
Adityanarayan Mohapatra, Padmanaban Sathiyamoorthy & In-Kyu Park. (2021) Metallic Nanoparticle-Mediated Immune Cell Regulation and Advanced Cancer Immunotherapy. Pharmaceutics 13:11, pages 1867.
Crossref
Crossref
Marie Donzel, Lucile Baseggio, Juliette Fontaine, Florian Pesce, Hervé Ghesquières, Emmanuel Bachy, Aurélie Verney & Alexandra Traverse-Glehen. (2021) New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas. Current Oncology 28:5, pages 3430-3447.
Crossref
Crossref
Xin Wei, Ziyan Feng, Jianbo Huang, Xi Xiang, Fangxue Du, Chao He, Mi Zhou, Lang Ma, Chong Cheng & Li Qiu. (2021) Homology and Immune Checkpoint Dual-Targeted Sonocatalytic Nanoagents for Enhancing Sonodynamic Tumor Therapy. ACS Applied Materials & Interfaces 13:28, pages 32810-32822.
Crossref
Crossref
Ruby Dhar, Ashikh Seethy, Sunil Singh, Karthikeyan Pethusamy, Tryambak Srivastava, Joyeeta Talukdar, GouraKishor Rath & Subhradip Karmakar. (2021) Cancer immunotherapy: Recent advances and challenges. Journal of Cancer Research and Therapeutics 17:4, pages 834.
Crossref
Crossref
Lukasz Kuryk, Laura Bertinato, Monika Staniszewska, Katarzyna Pancer, Magdalena Wieczorek, Stefano Salmaso, Paolo Caliceti & Mariangela Garofalo. (2020) From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review. Cancers 12:10, pages 3057.
Crossref
Crossref
Margherita Passariello, Simona Camorani, Cinzia Vetrei, Stefania Ricci, Laura Cerchia & Claudia De Lorenzo. (2020) Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. Cancers 12:2, pages 331.
Crossref
Crossref
Anna Maria Di Giacomo, Monica Valente, Alfonso Cerase, Maria Fortunata Lofiego, Francesca Piazzini, Luana Calabrò, Elisabetta Gambale, Alessia Covre & Michele Maio. (2019) Immunotherapy of brain metastases: breaking a “dogma”. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Yi-He Liu, Xin-Yuan Zang, Jin-Cheng Wang, Shan-Shan Huang, Jiang Xu & Peng Zhang. (2019) Diagnosis and Management of Immune Related Adverse Events (irAEs) in Cancer Immunotherapy. Biomedicine & Pharmacotherapy 120, pages 109437.
Crossref
Crossref
Katsiaryna Marhelava, Zofia Pilch, Malgorzata Bajor, Agnieszka Graczyk-Jarzynka & Radoslaw Zagozdzon. (2019) Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer. Cancers 11:11, pages 1756.
Crossref
Crossref
Wang Guan, Xiaoqin Zhang, Xiao Wang, Shun Lu, Jun Yin & Jinxin Zhang. (2019) Employing Parasite Against Cancer: A Lesson From the Canine Tapeworm Echinococcus Granulocus. Frontiers in Pharmacology 10.
Crossref
Crossref
Francesco Perri, Salvatore Pisconti, Matteo Favia, Giuseppina Della Vittoria Scarpati, Manuel Conson, Mario Giuliano, Franco Ionna, Francesco Longo, Bonamonte Domenico, Eugenio Maiorano & Gianfranco Favia. (2017) Optimal multidisciplinary treatment of oral cavity mucosal melanoma. Anti-Cancer Drugs 28:3, pages 327-334.
Crossref
Crossref